Changing Pharma Industry Attitudes to Regulatory Information Management (Scrips Regulatory Affairs article)

Adam Sherlock, Director of CSC Life Sciences, uncovers evolving attitudes to regulatory information management and explores the challenges and opportunities relating to implementation. In the data rich world of pharmaceutical R&D, the ability to access and use information is critical. The realisation that most methods of gathering, tracking and repurposing those data are insufficient has led to regulatory information management (Reg IM) becoming broadly accepted by the wider enterprise and even gaining a foothold as a  discrete displicine. Read the full article in Scrip Regulatory Affairs (PDF, 299KB).

For more information, please contact us.